ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 70 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $18,000 | -69.5% | 14,820 | -44.9% | 0.03% | +800.0% |
| Q3 2019 | $59,000 | -80.4% | 26,873 | -77.4% | 0.00% | -82.4% |
| Q2 2019 | $301,000 | +25.9% | 119,073 | +15.3% | 0.02% | +13.3% |
| Q4 2018 | $239,000 | +77.0% | 103,271 | +193.4% | 0.02% | +150.0% |
| Q3 2018 | $135,000 | -2.2% | 35,198 | -14.1% | 0.01% | 0.0% |
| Q2 2018 | $138,000 | -11.0% | 40,998 | -44.6% | 0.01% | 0.0% |
| Q1 2018 | $155,000 | -44.2% | 73,998 | -46.1% | 0.01% | -50.0% |
| Q4 2017 | $278,000 | +456.0% | 137,398 | +486.7% | 0.01% | +300.0% |
| Q2 2017 | $50,000 | +28.2% | 23,418 | +87.1% | 0.00% | +50.0% |
| Q1 2017 | $39,000 | -85.4% | 12,518 | -82.1% | 0.00% | -84.6% |
| Q4 2015 | $268,000 | +553.7% | 69,754 | +554.4% | 0.01% | +1200.0% |
| Q1 2015 | $41,000 | -78.3% | 10,660 | -62.2% | 0.00% | -85.7% |
| Q4 2014 | $189,000 | +92.9% | 28,223 | +57.0% | 0.01% | +40.0% |
| Q3 2014 | $98,000 | -88.9% | 17,979 | -78.1% | 0.01% | -89.6% |
| Q3 2013 | $884,000 | – | 82,006 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,995,760 | $16,129,000 | 1.12% |
| Palo Alto Investors LP | 1,425,439 | $3,834,000 | 0.29% |
| Granahan Investment Management | 1,438,736 | $3,870,000 | 0.14% |
| WealthTrust Axiom LLC | 130,000 | $349,000 | 0.13% |
| SHEPHERD KAPLAN KROCHUK, LLC | 127,846 | $344,000 | 0.09% |
| NIPPON LIFE INSURANCE CO | 17,192 | $2,247,000 | 0.06% |
| Joel Isaacson & Co., LLC | 80,660 | $217,000 | 0.05% |
| Cornerstone Capital, Inc. | 47,200 | $127,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 153,769 | $414,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,650 | $758,000 | 0.01% |